Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Colorectal CancerHead and Neck Cancer
Interventions
BIOLOGICAL

Urelumab

BIOLOGICAL

Cetuximab

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

15213

Upmc Cancer Center, Pittsburgh

21287

Johns Hopkins University, Baltimore

60637

University Of Chicago, Chicago

94305

Stanford University, Stanford

97213

Providence Oncology & Hematology Care Eastside, Portland

02215

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY